142 related articles for article (PubMed ID: 10606947)
1. Delayed diagnosis of glucagonoma syndrome.
Alkemade JA; van Tongeren JH; van Haelst UJ; Smals A; Steijlen PM; van de Kerkhof PC
Clin Exp Dermatol; 1999 Nov; 24(6):455-7. PubMed ID: 10606947
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic migratory erythema associated with glucagonoma syndrome.
Shi W; Liao W; Mei X; Xiao Q; Zeng Y; Zhou Q
J Clin Oncol; 2010 Jul; 28(20):e329-31. PubMed ID: 20530273
[No Abstract] [Full Text] [Related]
3. Glucagonoma syndrome: survival 24 years following diagnosis.
Nightingale KJ; Davies MG; Kingsnorth AN
Dig Surg; 1999; 16(1):68-71. PubMed ID: 9949270
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema (glucagonoma syndrome).
Myatt AE; Hargreaves GK
J R Soc Med; 1984; 77 Suppl 4(Suppl 4):31-2. PubMed ID: 6096544
[No Abstract] [Full Text] [Related]
5. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
6. [Erythema necroticans migrans without glucagonoma].
Tanner M; Brasch J; Christophers E
Hautarzt; 1994 Jul; 45(7):480-3. PubMed ID: 7928344
[TBL] [Abstract][Full Text] [Related]
7. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
8. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
Gantcheva ML; Broshtilova VK; Lalova AI
Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
[No Abstract] [Full Text] [Related]
9. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
10. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
[TBL] [Abstract][Full Text] [Related]
11. [Glucagonoma without glucagonoma syndrome].
Colović R; Matić S; Micev M; Grubor N; Latincić S
Srp Arh Celok Lek; 2010; 138(3-4):244-7. PubMed ID: 20499510
[TBL] [Abstract][Full Text] [Related]
12. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
13. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
Chen HW; Chen HW; Su DH; Shun CT; Liu KL
J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
[TBL] [Abstract][Full Text] [Related]
14. [Necrolytic migratory erythema in a patient with a glucagonoma].
Demirbas M; Prens B
Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
[TBL] [Abstract][Full Text] [Related]
15. Glucagonoma without cutaneous manifestations.
Parr JH; Ramsay ID; Keeling PW; Thompson RP; Mallinson CN
Postgrad Med J; 1985 Aug; 61(718):737-8. PubMed ID: 2994032
[TBL] [Abstract][Full Text] [Related]
16. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
17. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
Johnson SM; Smoller BR; Lamps LW; Horn TD
J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
[TBL] [Abstract][Full Text] [Related]
18. Migratory necrolytic erythema and glucagonoma.
Echenique-Elizondo M; Elorza JL; De Delas JS
Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
[No Abstract] [Full Text] [Related]
19. [Necrolytic migratory erythema in glucagonoma syndrome].
Stark I; Mensing CH; Sander CA
Hautarzt; 2008 Jan; 59(1):50-3. PubMed ID: 17549440
[TBL] [Abstract][Full Text] [Related]
20. [Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
Ossowski B; Baum C
Hautarzt; 1995 Mar; 46(3):173-6. PubMed ID: 7759243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
